RxDoctor Payments Data

Juliet Marquez

Acute Care · South Miami, FLNPI 1154846624

Payments from drug & device makers

$3,007in general payments, 2019–2025

Across 124 payments — averaging $24.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$460
  • Pfizer$360
  • Boston Scientific$288
  • Novo Nordisk$209
  • E.r. Squibb & Sons, L.L.C.$194
  • Bridgebio Pharma, Inc.$192
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$3,007100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,007 in reported general payments places this provider in the 90th percentile of 1,150 acute care providers in Florida.

See all acute care providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban56$67,395
Repatha SureclickEvolocumab56$41,515
EntrestoSacubitril/Valsartan38$33,358
MounjaroTirzepatide13$10,365
VascepaIcosapent Ethyl24$9,943
OzempicSemaglutide13$9,821
FarxigaDapagliflozin Propanediol13$8,593
Isosorbide Dinitrate65$3,803
Metoprolol Succinate112$1,545
Nifedipine ErNifedipine60$1,510
Losartan Potassium150$1,506
Omega-3 Acid Ethyl Esters11$1,422
Hydralazine Hcl99$1,356
Atorvastatin Calcium122$1,081
Nebivolol Hcl20$1,041

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$360$67,39556 claims
NovartisEntresto$93$33,35838 claims
Lilly USA, LLCMounjaro$116$10,36513 claims
Novo NordiskOzempic$209$9,82113 claims
AstraZenecaFarxiga$190$8,59313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,150 acute care providers in Florida.

Other acute care in South Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →